We thank B. Vogelstein (Johns Hopkins Oncology Center) for providing the Isogenic human DLD-1 CRC cell lines expressing either wild-type or mutant K-RAS (D-WT and D-MT cells, respectively). This evidence concerns the gene KRAS and colorectal carcinoma.